Financing Guide · Weight Loss Clinic

How to Finance a Weight Loss Clinic Acquisition

From SBA 7(a) loans to PE-backed recapitalizations, understand the capital stack options for acquiring a profitable medical weight loss practice in today's market.

Medical weight loss clinics generating $1M–$5M in revenue are among the most financeable healthcare businesses in the lower middle market. Cash-pay recurring revenue models, strong EBITDA margins, and SBA eligibility make these practices attractive to lenders. However, buyers must navigate lender sensitivity around GLP-1 prescribing compliance, provider key-person risk, and payer mix before securing optimal financing terms.

Financing Options for Weight Loss Clinic Acquisitions

SBA 7(a) Loan

$500K–$5MPrime + 2.75%–3.5% (variable)

The most common financing vehicle for weight loss clinic acquisitions. Covers 80–90% of the purchase price with competitive rates, low equity requirements, and 10-year repayment terms suited to healthcare cash flows.

Pros

  • Low buyer equity injection of 10–20%, preserving capital for post-close working capital and staff retention
  • SBA lenders familiar with medical practices accept cash-pay recurring revenue models common in weight loss clinics
  • 10-year amortization produces manageable monthly debt service relative to clinic EBITDA margins

Cons

  • ×Lenders scrutinize GLP-1 prescribing compliance and telemedicine protocols, which can slow underwriting timelines
  • ×Key-person dependency on an owner-physician may require a transition agreement or management guarantee from the seller
  • ×SBA loans require personal guarantee from the buyer, exposing personal assets if clinic performance declines post-acquisition

Seller Financing with Earnout

$150K–$750K (subordinated to SBA or senior debt)6%–8% fixed, interest-only periods common

Seller carries a portion of the purchase price — typically 10–25% — structured as a subordinated note or earnout tied to patient retention rates and revenue milestones over 12–24 months post-close.

Pros

  • Bridges valuation gaps when buyer and seller disagree on forward revenue projections tied to GLP-1 program growth
  • Earnout tied to patient retention metrics aligns seller incentives with a successful ownership transition
  • Reduces buyer's upfront equity requirement and signals seller confidence in business sustainability to SBA lenders

Cons

  • ×Earnout disputes are common if patient churn metrics or revenue definitions are not precisely documented in the purchase agreement
  • ×Seller subordination to SBA debt limits seller's security, making some physician-owners reluctant to accept this structure
  • ×Seller note servicing adds to monthly obligations, compressing early-stage post-acquisition cash flow for the buyer

PE-Backed Partial Recapitalization

$1M–$5M equity check depending on platform size and EBITDAEquity-based; no fixed interest rate — returns driven by platform EBITDA multiple expansion

A PE-backed healthcare rollup acquires a majority stake (60–80%), with the selling physician retaining 20–40% equity to participate in platform upside through a future liquidity event.

Pros

  • Seller achieves immediate liquidity while retaining upside through a second-bite equity stake in a larger platform
  • PE platforms provide operational resources — billing, compliance, marketing — reducing buyer execution risk post-close
  • Ideal structure for multi-location clinics with $500K+ EBITDA seeking a strategic growth partner over a pure financial buyer

Cons

  • ×Seller loses operational control and must align with platform protocols, which may conflict with existing clinical workflows
  • ×PE rollup valuations in medical weight loss are sensitive to GLP-1 regulatory risk, potentially compressing multiples during diligence
  • ×Retained equity is illiquid until a platform exit event, which may take 4–7 years depending on PE fund timelines

Sample Capital Stack

$2,000,000 (represents a weight loss clinic at ~4.5x EBITDA on $445K adjusted EBITDA)

Purchase Price

~$17,500/month combined (SBA P&I at prime + 3% over 10 years plus seller note interest-only payments)

Monthly Service

Approximately 1.45x DSCR based on $445K EBITDA — above the 1.25x minimum threshold most SBA healthcare lenders require

DSCR

SBA 7(a) loan: $1,600,000 (80%) | Seller note tied to 12-month patient retention milestone: $200,000 (10%) | Buyer equity injection: $200,000 (10%)

Lender Tips for Weight Loss Clinic Acquisitions

  • 1Present a compliance package upfront — include current DEA registrations, state medical licenses, and documented GLP-1 prescribing protocols to accelerate SBA underwriting and reduce lender risk flags.
  • 2Normalize financials with a clear EBITDA bridge that separates owner-physician compensation from a market-rate medical director salary, demonstrating sustainable earnings to lenders post-transition.
  • 3Document patient retention cohort data showing 12–24 month average program duration and low churn — lenders treat recurring membership revenue more favorably than one-time program enrollments.
  • 4Engage an SBA lender with a dedicated healthcare or medical practice lending division; generalist lenders often struggle to underwrite cash-pay clinical businesses without specialized healthcare portfolio experience.

Frequently Asked Questions

Are weight loss clinics eligible for SBA 7(a) financing?

Yes. Medical weight loss clinics with clean licensing histories, documented recurring revenue, and no passive income dependency are generally SBA-eligible. Cash-pay membership models are viewed favorably by most SBA healthcare lenders.

How does GLP-1 prescribing compliance affect lender approval?

Lenders increasingly request documentation of GLP-1 prescribing protocols, telehealth compliance, and compounding pharmacy sourcing. Unresolved regulatory exposure or state board complaints can delay approval or require escrow holdbacks.

What EBITDA threshold do I need to qualify for acquisition financing?

Most SBA lenders and PE platforms require minimum $300K–$500K in adjusted EBITDA. This ensures sufficient DSCR above 1.25x after normalizing for a market-rate medical director and post-close debt service obligations.

Can I use an earnout to bridge a valuation gap with the seller?

Yes, and it is common in weight loss clinic deals. Tie earnout milestones to specific patient retention rates or monthly recurring revenue thresholds — vague revenue targets frequently lead to post-close disputes between buyers and sellers.

More Weight Loss Clinic Guides

Ready to finance your Weight Loss Clinic acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required